Page 1

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , DC 20549 FORM 10 - Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31 , 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36362 BioLife Solutions , Inc. ( Exact name of registrant as specified in its charter ) BIOLIFE SOLUTIONS cell and gene therapy tools Delaware ( State or other jurisdiction of incorporation or organization ) 94-3076866 ( IRS Employer Identification No. ) 3303 Monte Villa Parkway , Suite 310 , Bothell , Washington , 98021 ( Address of registrant's principal executive offices , Zip Code ) ( 425 ) 402-1400 ( Telephone number , including area code ) Securities registered pursuant to Section 12 ( b ) of the Act : Title of each class BioLife Solutions , Inc. Common Shares Trading symbol BLFS Name of exchange on which registered NASDAQ Capital Market Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( S232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the Registrant was required to submit said files ) . Yes ✓ No ☐ Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company or an emerging growth company . See the definitions of “ large accelerated filer ” , “ accelerated filer ” , “ smaller reporting company ” and “ emerging growth company ” in Rule 12b - 2 of the Exchange Act . Large accelerated filer ☐ Company ☐ Accelerated filer Non - accelerated filer ☑ Smaller reporting company ☑ Emerging Growth